<SEC-DOCUMENT>0001193125-24-053649.txt : 20240229
<SEC-HEADER>0001193125-24-053649.hdr.sgml : 20240229
<ACCEPTANCE-DATETIME>20240229171343
ACCESSION NUMBER:		0001193125-24-053649
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20240229
DATE AS OF CHANGE:		20240229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIDUS INVESTMENT Corp
		CENTRAL INDEX KEY:			0001513363
		ORGANIZATION NAME:           	
		IRS NUMBER:				275017321
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253525
		FILM NUMBER:		24705074

	BUSINESS ADDRESS:	
		STREET 1:		1603 ORRINGTON AVENUE
		STREET 2:		SUITE 820
		CITY:			EVANSTON
		STATE:			IL
		ZIP:			60201
		BUSINESS PHONE:		847-859-3940

	MAIL ADDRESS:	
		STREET 1:		1603 ORRINGTON AVENUE
		STREET 2:		SUITE 820
		CITY:			EVANSTON
		STATE:			IL
		ZIP:			60201
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d767473d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ck0001513363="http://www.FIDUSINVESTMENTCorp.com/20240229" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>424B3</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P02_29_2024To02_29_2024" id="ixv-378">0001513363</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P02_29_2024To02_29_2024" id="ixv-379">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="P02_29_2024To02_29_2024" id="ixv-380">424B3</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P02_29_2024To02_29_2024" id="ixv-381">FIDUS INVESTMENT Corp</ix:nonNumeric><ix:footnote id="FN_348140" xml:lang="en-US">Represents the Sales Agents&#8217; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus.</ix:footnote><ix:footnote id="FN_348141" xml:lang="en-US">The offering expenses of this offering are estimated to be approximately $0.7 million, of which we have incurred $0.4 million as of February 28, 2024.</ix:footnote><ix:footnote id="FN_348142" xml:lang="en-US">The expenses of administering our dividend reinvestment plan are included in other expenses.</ix:footnote><ix:footnote id="FN_348143" xml:lang="en-US">Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December 31, 2023.</ix:footnote><ix:footnote id="FN_348144" xml:lang="en-US">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December 31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#8220;Investment Advisory Agreement&#8221;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#8220;Business&#8212;Management and Other Agreements&#8212;Investment Advisory Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form 10-K.</ix:footnote><ix:footnote id="FN_348145" xml:lang="en-US">This item represents actual fees incurred on pre-incentive fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December 31, 2023. The capital gains incentive fee payable as of December 31, 2023 was $17.5 million. For the year ended December 31, 2023, we accrued capital gains incentive fees (reversal) of $2.4 million in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. The incentive fee consists of two parts: The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and a &#8220;catch-up&#8221; provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our pre-incentive fee net investment income equals the hurdle rate of 2.0% but then receives, as a &#8220;catch-up,&#8221; 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if pre-incentive fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of our pre-incentive fee net investment income as if a hurdle rate did not apply. The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation.</ix:footnote><ix:footnote id="FN_348146" xml:lang="en-US">As of December 31, 2023, we had outstanding SBA debentures of $210.0 million; we had $250.0 million outstanding of our (i) 4.75% notes due 2026 (the &#8220;January 2026 Notes&#8221;), and (ii) 3.50% notes due 2026 (the &#8220;November 2026 Notes&#8221; and together with the January 2026 Notes, the &#8220;Notes&#8221;); we had secured borrowings outstanding of $15.9 million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#8220;Credit Facility&#8221;), which has a total commitment of $100.0 million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December 31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table. </ix:footnote><ix:footnote id="FN_348147" xml:lang="en-US">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December 31, 2023, including professional fees, directors&#8217; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#8220;Business&#8212;Management and Other Agreements&#8212;Administration Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form 10-K. Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#8220;Other expenses&#8221; are based on actual other expenses for the year ended December 31, 2023. </ix:footnote><ix:footnote id="FN_348148" xml:lang="en-US">&#8220;Total annual expenses, before base management fee waiver&#8221; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets.</ix:footnote><ix:footnote id="FN_348149" xml:lang="en-US">The Board of Directors accepted a voluntary, non-contractual, and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December 31, 2023. The base management fee waived for the year ended December 31, 2023 was $0.3 million. </ix:footnote><ix:footnote id="FN_348150" xml:lang="en-US">The SEC requires that the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage were calculated instead as a percentage of average consolidated total assets, our &#8220;total annual expenses, net of base management fee waiver&#8221; would be 6.56% of average consolidated total assets.</ix:footnote></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ck0001513363-20240229.xsd"/></ix:references><ix:resources><xbrli:context id="P02_29_2024To02_29_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001513363</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-29</xbrli:startDate> <xbrli:endDate>2024-02-29</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001513363</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-29</xbrli:startDate> <xbrli:endDate>2024-02-29</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001513363</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-29</xbrli:startDate> <xbrli:endDate>2024-02-29</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_29_2024To02_29_2024_CommonSharesMemberusgaapStatementClassOfStockAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001513363</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:CommonSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-29</xbrli:startDate> <xbrli:endDate>2024-02-29</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><ix:relationship fromRefs="Fact_100772074" toRefs="FN_348140"></ix:relationship><ix:relationship fromRefs="Fact_100772075" toRefs="FN_348141"></ix:relationship><ix:relationship fromRefs="Fact_100772076" toRefs="FN_348142"></ix:relationship><ix:relationship fromRefs="Fact_100772078" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772078" toRefs="FN_348144"></ix:relationship><ix:relationship fromRefs="Fact_100772079" toRefs="FN_348145"></ix:relationship><ix:relationship fromRefs="Fact_100772079" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772080" toRefs="FN_348146"></ix:relationship><ix:relationship fromRefs="Fact_100772080" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772081" toRefs="FN_348147"></ix:relationship><ix:relationship fromRefs="Fact_100772081" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772082" toRefs="FN_348148"></ix:relationship><ix:relationship fromRefs="Fact_100772082" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772083" toRefs="FN_348149"></ix:relationship><ix:relationship fromRefs="Fact_100772083" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772084" toRefs="FN_348143"></ix:relationship><ix:relationship fromRefs="Fact_100772084" toRefs="FN_348150"></ix:relationship></ix:resources></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">Filed Pursuant to Rule 424(b)(3) </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">File <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-253525</div> </div></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img alt="LOGO" src="g767473g0217022321170.jpg"/> </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Up to $300,000,000 </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Common Stock </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Supplement No.&#160;6, dated February&#160;29, 2024 </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">to </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Prospectus, dated May&#160;3, 2021 </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Prospectus Supplement, dated November&#160;10, 2022 </div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This supplement amends, supplements or modifies certain information contained in the prospectus supplement, dated November&#160;10, 2022 (the &#8220;ATM Prospectus Supplement&#8221;), and the accompanying prospectus, dated May&#160;3, 2021 (the &#8220;Base Prospectus&#8221; and together with the ATM Prospectus Supplement, any supplements thereto and the documents deemed incorporated by reference in each, the &#8220;Prospectus&#8221;), which relate to the sale of shares of common stock of Fidus Investment Corporation in an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;at-the-market&#8221;</div></div> offering (the &#8220;ATM Program&#8221;) pursuant to the equity distribution agreement (as described below). Capitalized terms used but not defined herein shall have the same meaning given them in the ATM Prospectus Supplement. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should carefully read the entire Prospectus and this supplement before investing in our common stock. This supplement should be read in conjunction with the Prospectus. <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">You should also carefully consider the information set forth under the sections titled &#8220;Risk Factors&#8221; on page 11 of the Base Prospectus and in our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for the fiscal year ended December</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">&#160;31, 2023, which is incorporated by reference into the Prospectus, as well as in our subsequent filings with the Securities and Exchange Commission that are incorporated into the Prospectus, before investing in our common stock.</div></div></div> </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This supplement is being filed to reflect that, on February&#160;29, 2024, we increased the maximum amount of shares of our common stock to be sold through the ATM Program to $300,000,000 from $150,000,000. In connection with the upsize of the ATM Program to $300,000,000, we entered into amendment no. 2 (&#8220;Amendment No.&#160;2&#8221;) to the equity distribution agreement, dated November&#160;10, 2022, with Raymond James&#160;&amp; Associates, Inc. (&#8220;Raymond James&#8221;) and B. Riley Securities, Inc. (&#8220;B. Riley&#8221; and, together with Raymond James, the &#8220;Sales Agents&#8221;). </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">STATUS OF THE <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;AT-THE-MARKET&#8221;</div></div> OFFERING </div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From November&#160;10, 2022 to December&#160;31, 2023, we sold a total of 5,970,743 shares of our common stock under the ATM Program for gross proceeds of approximately $117.8&#160;million and net proceeds of approximately $116.2&#160;million, after deducting commissions to the Sales Agents on shares sold and offering expenses. From January&#160;1, 2024 to February&#160;28, 2024, we sold a total of 207,530 shares of our common stock under the ATM Program for gross proceeds of approximately $4.1&#160;million and net proceeds of approximately $4.1&#160;million, after deducting commissions to the Sales Agents on shares sold and offering expenses.</div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&#160;28, 2024, after giving effect to the upsize of the ATM Program under Amendment No.&#160;2, up to approximately $178.1&#160;million in aggregate amount of our common stock remains available for sale under the ATM Program. </div></div></div></div> <div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">FEES AND EXPENSES </div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="cef:PurposeOfFeeTableNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-447">The following table is intended to assist you in understanding the costs and expenses that an investor in our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this supplement contains a reference to fees or expenses paid by &#8220;us&#8221; or that &#8220;we&#8221; will pay fees or expenses, common stockholders will indirectly bear such fees or expenses.</ix:nonNumeric> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="cef:ShareholderTransactionExpensesTableTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" continuedAt="TextSelection_100772103" id="ixv-59">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width: 85%;"/>
<td style="vertical-align: bottom; width: 8%;"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Stockholder transaction expenses:</div></div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales load (<ix:nonNumeric name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-448">as a percentage of offering price</ix:nonNumeric>)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772074">1.50</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%(1)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering Expenses borne by us (<ix:nonNumeric name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-450">as a percentage of offering price</ix:nonNumeric>)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:OtherTransactionExpense1Percent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772075">0.44</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%(2)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend reinvestment plan expenses</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="Fact_100772076">&#8212;</ix:nonFraction>&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">(3)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;"/>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stockholder transaction expenses paid by us (<ix:nonNumeric name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-453">as a percentage of offering price</ix:nonNumeric>)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-454">1.94</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;"/>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table></ix:nonNumeric><div style="margin-top: 0px; margin-bottom: 0px;">&#160;</div><ix:nonNumeric name="cef:AnnualExpensesTableTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" continuedAt="TextSelection_100772104" id="ixv-120">
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Annual expenses (<ix:nonNumeric name="cef:BasisOfTransactionFeesNoteTextBlock" contextRef="P02_29_2024To02_29_2024_CommonSharesMemberusgaapStatementClassOfStockAxis" escape="true" id="ixv-455">as a percentage of net assets attributable to common stock</ix:nonNumeric>) (4):</div></div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"/>
<td style="vertical-align: bottom;;width:1%;"/>
<td style="vertical-align: bottom;;width:1%;"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Base management fee</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772078">3.15</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(5)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Incentive fees payable under Investment Advisory Agreement</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:IncentiveFeesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772079">3.88</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(6)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payments on borrowed funds</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772080">4.24</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(7)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other expenses</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772081">1.42</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(8)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"/>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total annual expenses, before base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772082">12.69</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(9)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">(<ix:nonFraction name="cef:WaiversAndReimbursementsOfFeesPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" sign="-" format="ixt:num-dot-decimal" id="Fact_100772083">0.06</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">)%(10)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"/>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total annual expenses, net of base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"><ix:nonFraction name="cef:NetExpenseOverAssetsPercent" contextRef="P02_29_2024To02_29_2024" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="Fact_100772084">12.63</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(11)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"/>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></ix:nonNumeric><ix:continuation id="TextSelection_100772103">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the Sales Agents&#8217; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The offering expenses of this offering are estimated to be approximately $0.7&#160;million, of which we have incurred $0.4&#160;million as of February&#160;28, 2024. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The expenses of administering our dividend reinvestment plan are included in other expenses. </div></td></tr></table></ix:continuation><ix:continuation id="TextSelection_100772104">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(4)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December&#160;31, 2023. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(5)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><ix:nonNumeric name="cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-231">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December&#160;31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#8220;Investment Advisory Agreement&#8221;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#8220;Business&#8212;Management and Other Agreements&#8212;Investment Advisory Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div></ix:nonNumeric><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div> </div></td></tr></table><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%"/></ix:exclude>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(6)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">This item represents actual fees incurred on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December&#160;31, 2023. The capital gains incentive fee payable as of December&#160;31, 2023 was $17.5&#160;million. For the year ended December&#160;31, 2023, we accrued capital gains incentive fees (reversal) of $2.4&#160;million in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The incentive fee consists of two parts: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The first, payable quarterly in arrears, equals 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;pre-incentive</div> fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a&#160;&#8220;catch-up&#8221;</div> provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income equals the hurdle rate of 2.0% but then receives, as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;catch-up,&#8221;&#160;100.0%</div> of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">such&#160;pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;pre-incentive</div> fee net investment income as if a hurdle rate did not apply. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(7)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">As of December&#160;31, 2023, we had outstanding SBA debentures of $210.0&#160;million; we had $250.0&#160;million outstanding of our (i) 4.75% notes due 2026 (the &#8220;January 2026 Notes&#8221;), and (ii) 3.50% notes due 2026 (the &#8220;November 2026 Notes&#8221; and together with the January 2026 Notes, the &#8220;Notes&#8221;); we had secured borrowings outstanding of $15.9&#160;million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#8220;Credit Facility&#8221;), which has a total commitment of $100.0&#160;million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December&#160;31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(8)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><ix:nonNumeric name="cef:OtherExpensesNoteTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" id="ixv-266">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December&#160;31, 2023, including professional fees, directors&#8217; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#8220;Business&#8212;Management and Other Agreements&#8212;Administration Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#8220;Other expenses&#8221; are based on actual other expenses for the year ended December&#160;31, 2023.</ix:nonNumeric> </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(9)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">&#8220;Total annual expenses, before base management fee waiver&#8221; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(10)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Board of Directors accepted a voluntary, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-contractual,</div> and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December&#160;31, 2023. The base management fee waived for the year ended December&#160;31, 2023 was $0.3&#160;million. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(11)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The SEC requires that the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage were calculated instead as a percentage of average consolidated total assets, our &#8220;total annual expenses, net of base management fee waiver&#8221; would be 6.56% of average consolidated total assets. </div></td></tr></table></ix:continuation><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><ix:nonNumeric name="cef:ExpenseExampleTableTextBlock" contextRef="P02_29_2024To02_29_2024" escape="true" continuedAt="TextSelection_100772094" id="ixv-286"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Example </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed we would have no additional leverage, that none of our assets are cash or cash equivalents and that our annual operating expenses would remain at the levels set forth in the table above. The stockholder transaction expenses described above are included in the following examples. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:72%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1&#160;year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-463">141</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-464">357</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-465">541</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-466">892</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return resulting entirely from net realized capital gains (all of which is subject to our incentive fee on capital gains)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-467">150</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-468">378</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-469">568</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-470">918</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table></ix:nonNumeric><ix:continuation id="TextSelection_100772094"> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5.0% annual return, our performance will vary and may result in a return greater or less than 5.0%. Assuming a 5.0% annual return, the incentive fee under the Investment Advisory Agreement would either not be payable or have an insignificant impact on the expense amounts shown above. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all distributions at net asset value, if our board of directors authorizes and we declare a cash dividend, participants in our dividend reinvestment plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the distribution. See &#8220;Part II, Item 5&#8221; in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for additional information regarding our dividend reinvestment plan. </div><div style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">These examples and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown. </div></div></ix:continuation></div><div></div></div></div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ck0001513363-20240229.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-February-2024 [02:38:46] {AM}-->
<schema targetNamespace="http://www.FIDUSINVESTMENTCorp.com/20240229" elementFormDefault="qualified" xmlns:ck0001513363="http://www.FIDUSINVESTMENTCorp.com/20240229" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2023">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.FIDUSINVESTMENTCorp.com/role/N2FeeTable" id="N2FeeTable">
<link:definition>1001 - Disclosure - N-2 - [Fee Table]</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="ck0001513363-20240229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="ck0001513363-20240229_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="ck0001513363-20240229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd" />
<import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd" />
<element name="CommonSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ck0001513363_CommonSharesMember" substitutionGroup="xbrli:item" />
<element name="YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" substitutionGroup="xbrli:item" />
<element name="YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ck0001513363-20240229_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-February-2024 [02:38:46] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_200072" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_CommonSharesMember" xlink:label="loc_ck0001513363_CommonSharesMember_200583" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_CommonSharesMember_200583" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember_200585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember_200585" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember_200584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember_200584" use="optional" order="3" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ck0001513363-20240229_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-February-2024 [02:38:46] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_CommonSharesMember" xlink:label="loc_ck0001513363_CommonSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001513363_CommonSharesMember" xml:lang="en-US">Common Shares [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001513363_CommonSharesMember" xlink:to="lab_ck0001513363_CommonSharesMember" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" xml:lang="en-US">You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" xlink:to="lab_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" xml:lang="en-US">You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return Resulting Entirely From Net Realized Capital Gains [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" xlink:to="lab_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ck0001513363-20240229_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 29-February-2024 [02:38:46] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_200074" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_200072" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_CommonSharesMember" xlink:label="loc_ck0001513363_CommonSharesMember_200583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_CommonSharesMember_200583" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember_200584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember_200584" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ck0001513363-20240229.xsd#ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember" xlink:label="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember_200585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_200072" xlink:to="loc_ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember_200585" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_200069" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g767473g0217022321170.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g767473g0217022321170.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) )$# 2(  A$! Q$!_\0
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M;QDQB"V4-(V3C@$C^=<5V[([-%J?./Q<_P"2C:I_N1?^BQ7T1X?_ .1;TO\
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@3CT-244 5GL87NH+@[A)""%P>"/>K-%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140311988950464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th" colspan="2">
<div>Feb. 29, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001513363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">424B3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FIDUS INVESTMENT Corp<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width: 85%;"></td>
<td style="vertical-align: bottom; width: 8%;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Stockholder transaction expenses:</div></div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales load (as a percentage of offering price)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.50</td>
<td style="white-space:nowrap;vertical-align:bottom">%(1)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering Expenses borne by us (as a percentage of offering price)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.44</td>
<td style="white-space:nowrap;vertical-align:bottom">%(2)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend reinvestment plan expenses</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">(3)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;"></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 85%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stockholder transaction expenses paid by us (as a percentage of offering price)</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.94</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 85%;"></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the Sales Agents&#8217; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The offering expenses of this offering are estimated to be approximately $0.7&#160;million, of which we have incurred $0.4&#160;million as of February&#160;28, 2024. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The expenses of administering our dividend reinvestment plan are included in other expenses. </div></td></tr></table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpense1Percent', window );">Other Transaction Expense 1 [Percent]</a></td>
<td class="nump">0.44%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="nump">1.94%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="text">
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Annual expenses (as a percentage of net assets attributable to common stock) (4):</div></div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"></td>
<td style="vertical-align: bottom;;width:1%;"></td>
<td style="vertical-align: bottom;;width:1%;"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Base management fee</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">3.15</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(5)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Incentive fees payable under Investment Advisory Agreement</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">3.88</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(6)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payments on borrowed funds</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">4.24</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(7)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other expenses</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">1.42</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(8)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total annual expenses, before base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">12.69</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(9)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">(0.06</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">)%(10)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align: top; width: 91%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total annual expenses, net of base management fee waiver</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:5%;">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;">12.63</td>
<td style="white-space: nowrap; vertical-align: bottom;;width:1%;">%(11)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; width: 91%;"></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="vertical-align: bottom;;width:5%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align: bottom;;width:1%;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="width:1%;">&#160;</td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(4)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December&#160;31, 2023. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(5)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December&#160;31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#8220;Investment Advisory Agreement&#8221;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#8220;Business&#8212;Management and Other Agreements&#8212;Investment Advisory Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div> </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(6)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">This item represents actual fees incurred on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December&#160;31, 2023. The capital gains incentive fee payable as of December&#160;31, 2023 was $17.5&#160;million. For the year ended December&#160;31, 2023, we accrued capital gains incentive fees (reversal) of $2.4&#160;million in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The incentive fee consists of two parts: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The first, payable quarterly in arrears, equals 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;pre-incentive</div> fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a&#160;&#8220;catch-up&#8221;</div> provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income equals the hurdle rate of 2.0% but then receives, as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;catch-up,&#8221;&#160;100.0%</div> of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">such&#160;pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;pre-incentive</div> fee net investment income as if a hurdle rate did not apply. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(7)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">As of December&#160;31, 2023, we had outstanding SBA debentures of $210.0&#160;million; we had $250.0&#160;million outstanding of our (i) 4.75% notes due 2026 (the &#8220;January 2026 Notes&#8221;), and (ii) 3.50% notes due 2026 (the &#8220;November 2026 Notes&#8221; and together with the January 2026 Notes, the &#8220;Notes&#8221;); we had secured borrowings outstanding of $15.9&#160;million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#8220;Credit Facility&#8221;), which has a total commitment of $100.0&#160;million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December&#160;31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(8)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December&#160;31, 2023, including professional fees, directors&#8217; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#8220;Business&#8212;Management and Other Agreements&#8212;Administration Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#8220;Other expenses&#8221; are based on actual other expenses for the year ended December&#160;31, 2023. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(9)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">&#8220;Total annual expenses, before base management fee waiver&#8221; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(10)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Board of Directors accepted a voluntary, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-contractual,</div> and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December&#160;31, 2023. The base management fee waived for the year ended December&#160;31, 2023 was $0.3&#160;million. </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(11)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The SEC requires that the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage were calculated instead as a percentage of average consolidated total assets, our &#8220;total annual expenses, net of base management fee waiver&#8221; would be 6.56% of average consolidated total assets. </div></td></tr></table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="nump">4.24%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IncentiveFeesPercent', window );">Incentive Fees [Percent]</a></td>
<td class="nump">3.88%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[7]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="nump">1.42%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="nump">12.69%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_WaiversAndReimbursementsOfFeesPercent', window );">Waivers and Reimbursements of Fees [Percent]</a></td>
<td class="num">(0.06%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[10]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NetExpenseOverAssetsPercent', window );">Net Expense over Assets [Percent]</a></td>
<td class="nump">12.63%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Example </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed we would have no additional leverage, that none of our assets are cash or cash equivalents and that our annual operating expenses would remain at the levels set forth in the table above. The stockholder transaction expenses described above are included in the following examples. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:72%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1&#160;year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10&#160;years</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;357</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;541</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;892</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return resulting entirely from net realized capital gains (all of which is subject to our incentive fee on capital gains)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;150</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">378</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">918</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5.0% annual return, our performance will vary and may result in a return greater or less than 5.0%. Assuming a 5.0% annual return, the incentive fee under the Investment Advisory Agreement would either not be payable or have an insignificant impact on the expense amounts shown above. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all distributions at net asset value, if our board of directors authorizes and we declare a cash dividend, participants in our dividend reinvestment plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the distribution. See &#8220;Part II, Item 5&#8221; in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> for additional information regarding our dividend reinvestment plan. </div><div style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">These examples and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown. </div></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="text">The following table is intended to assist you in understanding the costs and expenses that an investor in our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this supplement contains a reference to fees or expenses paid by &#8220;us&#8221; or that &#8220;we&#8221; will pay fees or expenses, common stockholders will indirectly bear such fees or expenses.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="text">as a percentage of offering price<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="text">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December&#160;31, 2023, including professional fees, directors&#8217; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#8220;Business&#8212;Management and Other Agreements&#8212;Administration Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#8220;Other expenses&#8221; are based on actual other expenses for the year ended December&#160;31, 2023.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock', window );">Management Fee not based on Net Assets, Note [Text Block]</a></td>
<td class="text">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December&#160;31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#8220;Investment Advisory Agreement&#8221;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#8220;Business&#8212;Management and Other Agreements&#8212;Investment Advisory Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001513363_CommonSharesMember', window );">Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="text">as a percentage of net assets attributable to common stock<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember', window );">You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return Resulting Entirely From Net Realized Capital Gains [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="nump">378<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="nump">568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="nump">918<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember', window );">You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="nump">141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="nump">357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="nump">541<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="nump">$ 892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the Sales Agents&#8217; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The expenses of administering our dividend reinvestment plan are included in other expenses.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The offering expenses of this offering are estimated to be approximately $0.7 million, of which we have incurred $0.4 million as of February 28, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December 31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#8220;Investment Advisory Agreement&#8221;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#8220;Business&#8212;Management and Other Agreements&#8212;Investment Advisory Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form 10-K.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2023, we had outstanding SBA debentures of $210.0 million; we had $250.0 million outstanding of our (i) 4.75% notes due 2026 (the &#8220;January 2026 Notes&#8221;), and (ii) 3.50% notes due 2026 (the &#8220;November 2026 Notes&#8221; and together with the January 2026 Notes, the &#8220;Notes&#8221;); we had secured borrowings outstanding of $15.9 million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#8220;Credit Facility&#8221;), which has a total commitment of $100.0 million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December 31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">This item represents actual fees incurred on pre-incentive fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December 31, 2023. The capital gains incentive fee payable as of December 31, 2023 was $17.5 million. For the year ended December 31, 2023, we accrued capital gains incentive fees (reversal) of $2.4 million in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. The incentive fee consists of two parts: The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and a &#8220;catch-up&#8221; provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our pre-incentive fee net investment income equals the hurdle rate of 2.0% but then receives, as a &#8220;catch-up,&#8221; 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if pre-incentive fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of our pre-incentive fee net investment income as if a hurdle rate did not apply. The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December 31, 2023, including professional fees, directors&#8217; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#8220;Business&#8212;Management and Other Agreements&#8212;Administration Agreement&#8221; in Part I, Item 1 in our most recent Annual Report on Form 10-K. Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#8220;Other expenses&#8221; are based on actual other expenses for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">&#8220;Total annual expenses, before base management fee waiver&#8221; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">The Board of Directors accepted a voluntary, non-contractual, and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December 31, 2023. The base management fee waived for the year ended December 31, 2023 was $0.3 million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">The SEC requires that the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#8220;total annual expenses, net of base management fee waiver&#8221; percentage were calculated instead as a percentage of average consolidated total assets, our &#8220;total annual expenses, net of base management fee waiver&#8221; would be 6.56% of average consolidated total assets.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IncentiveFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IncentiveFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NetExpenseOverAssetsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NetExpenseOverAssetsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpense1Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpense1Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_WaiversAndReimbursementsOfFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_WaiversAndReimbursementsOfFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001513363_CommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001513363_CommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M:Y;@/5<EZ="A\F+F:?2V_U(9+>3)S8=!=FR4OI:#<742!YVA/&#"L[73E=;
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( *F)75BV0E<F,@$  " "   /    >&PO=V]R:V)O;VLN>&ULC5'12L-
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M/UY_ 5!+ 0(4 Q0    ( *B)75@'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ J(E=6"V.77GM
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ J(E=6)E<G",0!@  G"<  !,              ( !RP$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "IB5U8@FCR^8\5  !<9P  &
M            @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ J8E=6+VC:& " P  :P\   T              ( !T1T  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "IB5U8EXJ[',     3 @  "P
M    @ '^(   7W)E;',O+G)E;'-02P$"% ,4    " "IB5U8MD)7)C(!   @
M @  #P              @ 'G(0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ J8E=6"0>FZ*M    ^ $  !H              ( !1B,  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ J8E=6&60>9(9 0  SP,
M !,              ( !*R0  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  =24

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="d767473d424b3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ck0001513363-20240229.xsd</File>
    <File>ck0001513363-20240229_def.xml</File>
    <File>ck0001513363-20240229_lab.xml</File>
    <File>ck0001513363-20240229_pre.xml</File>
    <File doctype="424B3" isUsgaap="true" original="d767473d424b3.htm">d767473d424b3.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g767473g0217022321170.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d767473d424b3.htm": {
   "nsprefix": "ck0001513363",
   "nsuri": "http://www.FIDUSINVESTMENTCorp.com/20240229",
   "dts": {
    "schema": {
     "local": [
      "ck0001513363-20240229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ck0001513363-20240229_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001513363-20240229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001513363-20240229_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d767473d424b3.htm"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 3,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 200,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2023": 29,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P02_29_2024To02_29_2024",
      "name": "cef:ShareholderTransactionExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d767473d424b3.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P02_29_2024To02_29_2024",
      "name": "cef:ShareholderTransactionExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d767473d424b3.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "ck0001513363_CommonSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.FIDUSINVESTMENTCorp.com/20240229",
     "localname": "CommonSharesMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r75"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r73",
      "r74"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r54"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.FIDUSINVESTMENTCorp.com/20240229",
     "localname": "YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ck0001513363_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.FIDUSINVESTMENTCorp.com/20240229",
     "localname": "YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "You Would Pay The Following Expenses On A1000 Investment Assuming A5.0 Annual Return Resulting Entirely From Net Realized Capital Gains [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-053649-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-053649-xbrl.zip
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M.__O-/Z!9)LGM[K32?TC7&Y5_T8'WP%02P,$%     @ J8E=6(A!]]OU @
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M(A7)<AW)4$G603&.HB2,$DZ?GY[]T>OOV?T.T?Q!X(!N;O"P_>VB<72.HET
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M9ZJ H0O<'')/R=+,)<O]C3H*N262*IWPI:2UGFZ1X=B.U<NMO?6V95!WO(L
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M)7@CGK (LCQ6JX!/W6.(7L^Q*#%,+1O*WUOECG,UIJI!Q=W\:'/I2:=V7M5
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M-*C;LQM'7T"<UD5+@*!M:W?P5A.OIN4K)TBY-@H+M^HVH_SR7-<14VIE1/_
M/IOP'9G!V$2[<I'N+3?G;JGVT3Y>U![G)K6Z_+L&?.-Z^0TX['=.K9?D]<S^
M3/9BQ_]BG +O=J?^JV37S&-?-6M7G6BIJQ/U"E<(*U\FC;F >>-Q6F?=G=,
MK=GB?&5&8=[&\UO6WLW>[W?8T%6-[-'X DB##,J()ETY*INE(J%FK^EHYB?*
MH"NT<:(;PQ$-L*OR0FI,6'VK>]&6^UP5A6,4EB\,;YKW+I?I"E9WP?,N_ZD
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M)>/D73780YKN6T)C$_X$ ::6E-O'OLA':<E+DA:5UUO+#'.%1@JD%SD#)5-
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M[=U1\4692+8]BKP%_#5-9L'1_P=02P,$%     @ J8E=6/@T8U&I#0  70X
M !D   !G-S8W-#<S9S R,3<P,C(S,C$Q-S N:G!GG91W-!7^_\??U[4I&3?K
M<LNELKF9F>%>]RJNS$+9NRBR,\O(R%9&J(SL4L+-RBYD9$7$-2^)['GO3Y_S
M&__\SO=\?[_G^\_7..?Q>KY>;\HH90J<TL'@,  "@0"KXP<HXT 3T-/2TM'2
MT-/1T3$PT#,R<YQ@9F)BYF9C9^'@XT'P\_' X6<$)<Z?$1!#PN$7Y(7%I*1E
M9&00YQ55%%#*$A=E4'^;0!@8&)B9F+E.G.!"G86?1?V?16D"K/0 !Q*A$ %
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MZRG :MQ]?JA+1U?8O'J/3U8@TQ15YTSDI8!=G$P\=-''W5&\S_+]+2@!.[,
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M]JXO<K*T'PTXKJ%!,.7[?P!02P$"% ,4    " "IB5U8AW:5M!,$   >$
M&0              @ $     8VLP,# Q-3$S,S8S+3(P,C0P,C(Y+GAS9%!+
M 0(4 Q0    ( *F)75APWD&AQP(  +P*   =              "  4H$  !C
M:S P,#$U,3,S-C,M,C R-# R,CE?9&5F+GAM;%!+ 0(4 Q0    ( *F)75B(
M0??;]0(  -<0   =              "  4P'  !C:S P,#$U,3,S-C,M,C R
M-# R,CE?;&%B+GAM;%!+ 0(4 Q0    ( *F)75C%,SNUV (  *D+   =
M          "  7P*  !C:S P,#$U,3,S-C,M,C R-# R,CE?<')E+GAM;%!+
M 0(4 Q0    ( *F)75@T2J/7>B@  %KV   1              "  8\-  !D
M-S8W-#<S9#0R-&(S+FAT;5!+ 0(4 Q0    ( *F)75CX-&-1J0T  %T.   9
M              "  3@V  !G-S8W-#<S9S R,3<P,C(S,C$Q-S N:G!G4$L%
3!@     &  8 K@$  !A$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d767473d424b3_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:ck0001513363="http://www.FIDUSINVESTMENTCorp.com/20240229"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001513363-20240229.xsd" xlink:type="simple"/>
    <context id="P02_29_2024To02_29_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001513363</identifier>
        </entity>
        <period>
            <startDate>2024-02-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001513363</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001513363</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA5.0AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="P02_29_2024To02_29_2024_CommonSharesMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001513363</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001513363:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P02_29_2024To02_29_2024" id="ixv-378">0001513363</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P02_29_2024To02_29_2024" id="ixv-379">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="P02_29_2024To02_29_2024" id="ixv-380">424B3</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="P02_29_2024To02_29_2024" id="ixv-381">FIDUS INVESTMENT Corp</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-447">The following table is intended to assist you in understanding the costs and expenses that an investor in our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this supplement contains a reference to fees or expenses paid by &#x201c;us&#x201d; or that &#x201c;we&#x201d; will pay fees or expenses, common stockholders will indirectly bear such fees or expenses.</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-59">
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width: 85%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Stockholder transaction expenses:&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Sales load (as a percentage of offering price)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.50&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%(1)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Offering Expenses borne by us (as a percentage of offering price)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.44&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%(2)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Dividend reinvestment plan expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#x2002;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;(3)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 85%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total stockholder transaction expenses paid by us (as a percentage of offering price)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.94&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 85%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Represents the Sales Agents&#x2019; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The offering expenses of this offering are estimated to be approximately $0.7&#160;million, of which we have incurred $0.4&#160;million as of February&#160;28, 2024. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The expenses of administering our dividend reinvestment plan are included in other expenses. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-448">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772074"
      unitRef="Unit_pure">0.015</cef:SalesLoadPercent>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-450">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpense1Percent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772075"
      unitRef="Unit_pure">0.0044</cef:OtherTransactionExpense1Percent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="P02_29_2024To02_29_2024"
      decimals="0"
      id="Fact_100772076"
      unitRef="Unit_USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-453">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpensesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="ixv-454"
      unitRef="Unit_pure">0.0194</cef:OtherTransactionExpensesPercent>
    <cef:AnnualExpensesTableTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-120">
&lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Annual expenses (as a percentage of net assets attributable to common stock) (4):&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:1%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:1%;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Base management fee&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;3.15&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(5)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Incentive fees payable under Investment Advisory Agreement&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;3.88&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(6)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Interest payments on borrowed funds&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;4.24&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(7)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Other expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;1.42&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(8)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 91%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:1%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width:1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total annual expenses, before base management fee waiver&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;12.69&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(9)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Base management fee waiver&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;(0.06&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;)%(10)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 91%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:1%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width:1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align: top; width: 91%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Total annual expenses, net of base management fee waiver&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;text-align:right;;width:1%;"&gt;12.63&lt;/td&gt;
&lt;td style="white-space: nowrap; vertical-align: bottom;;width:1%;"&gt;%(11)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align: bottom; width: 91%;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:5%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;width:1%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="width:1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(4)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December&#160;31, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(5)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December&#160;31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#x201c;Investment Advisory Agreement&#x201d;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Investment Advisory Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-K.&lt;/div&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(6)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;This item represents actual fees incurred on &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-incentive&lt;/div&gt; fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December&#160;31, 2023. The capital gains incentive fee payable as of December&#160;31, 2023 was $17.5&#160;million. For the year ended December&#160;31, 2023, we accrued capital gains incentive fees (reversal) of $2.4&#160;million in accordance with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"&gt;The incentive fee consists of two parts: &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"&gt;The first, payable quarterly in arrears, equals 20.0% of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;our&#160;pre-incentive&lt;/div&gt; fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;a&#160;&#x201c;catch-up&#x201d;&lt;/div&gt; provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-incentive&lt;/div&gt; fee net investment income equals the hurdle rate of 2.0% but then receives, as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;catch-up,&#x201d;&#160;100.0%&lt;/div&gt; of our &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-incentive&lt;/div&gt; fee net investment income with respect to that portion of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;such&#160;pre-incentive&lt;/div&gt; fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;pre-incentive&lt;/div&gt; fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;our&#160;pre-incentive&lt;/div&gt; fee net investment income as if a hurdle rate did not apply. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"&gt;The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(7)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;As of December&#160;31, 2023, we had outstanding SBA debentures of $210.0&#160;million; we had $250.0&#160;million outstanding of our (i) 4.75% notes due 2026 (the &#x201c;January 2026 Notes&#x201d;), and (ii) 3.50% notes due 2026 (the &#x201c;November 2026 Notes&#x201d; and together with the January 2026 Notes, the &#x201c;Notes&#x201d;); we had secured borrowings outstanding of $15.9&#160;million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#x201c;Credit Facility&#x201d;), which has a total commitment of $100.0&#160;million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December&#160;31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(8)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December&#160;31, 2023, including professional fees, directors&#x2019; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Administration Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-K.&lt;/div&gt; Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#x201c;Other expenses&#x201d; are based on actual other expenses for the year ended December&#160;31, 2023. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(9)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;&#x201c;Total annual expenses, before base management fee waiver&#x201d; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(10)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The Board of Directors accepted a voluntary, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-contractual,&lt;/div&gt; and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December&#160;31, 2023. The base management fee waived for the year ended December&#160;31, 2023 was $0.3&#160;million. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(11)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;The SEC requires that the &#x201c;total annual expenses, net of base management fee waiver&#x201d; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#x201c;total annual expenses, net of base management fee waiver&#x201d; percentage were calculated instead as a percentage of average consolidated total assets, our &#x201c;total annual expenses, net of base management fee waiver&#x201d; would be 6.56% of average consolidated total assets. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="P02_29_2024To02_29_2024_CommonSharesMemberusgaapStatementClassOfStockAxis"
      id="ixv-455">as a percentage of net assets attributable to common stock</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:ManagementFeesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772078"
      unitRef="Unit_pure">0.0315</cef:ManagementFeesPercent>
    <cef:IncentiveFeesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772079"
      unitRef="Unit_pure">0.0388</cef:IncentiveFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772080"
      unitRef="Unit_pure">0.0424</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772081"
      unitRef="Unit_pure">0.0142</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772082"
      unitRef="Unit_pure">0.1269</cef:TotalAnnualExpensesPercent>
    <cef:WaiversAndReimbursementsOfFeesPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772083"
      unitRef="Unit_pure">-0.0006</cef:WaiversAndReimbursementsOfFeesPercent>
    <cef:NetExpenseOverAssetsPercent
      contextRef="P02_29_2024To02_29_2024"
      decimals="4"
      id="Fact_100772084"
      unitRef="Unit_pure">0.1263</cef:NetExpenseOverAssetsPercent>
    <cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-231">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December&#160;31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#x201c;Investment Advisory Agreement&#x201d;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Investment Advisory Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-K.&lt;/div&gt;</cef:ManagementFeeNotBasedOnNetAssetsNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-266">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December&#160;31, 2023, including professional fees, directors&#x2019; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Administration Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-K.&lt;/div&gt; Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#x201c;Other expenses&#x201d; are based on actual other expenses for the year ended December&#160;31, 2023.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="P02_29_2024To02_29_2024" id="ixv-286">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Example &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed we would have no additional leverage, that none of our assets are cash or cash equivalents and that our annual operating expenses would remain at the levels set forth in the table above. The stockholder transaction expenses described above are included in the following examples. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:72%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1&#160;year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10&#160;years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;141&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;357&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;541&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;892&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;You would pay the following expenses on a $1,000 investment, assuming a 5.0% annual return resulting entirely from net realized capital gains (all of which is subject to our incentive fee on capital gains)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;150&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;378&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;568&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;918&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5.0% annual return, our performance will vary and may result in a return greater or less than 5.0%. Assuming a 5.0% annual return, the incentive fee under the Investment Advisory Agreement would either not be payable or have an insignificant impact on the expense amounts shown above. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all distributions at net asset value, if our board of directors authorizes and we declare a cash dividend, participants in our dividend reinvestment plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the distribution. See &#x201c;Part II, Item 5&#x201d; in our most recent Annual Report on Form &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;10-K&lt;/div&gt; for additional information regarding our dividend reinvestment plan. &lt;/div&gt;&lt;div style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;These examples and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown. &lt;/div&gt;&lt;/div&gt;</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-463"
      unitRef="Unit_USD">141</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-464"
      unitRef="Unit_USD">357</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-465"
      unitRef="Unit_USD">541</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-466"
      unitRef="Unit_USD">892</cef:ExpenseExampleYears1to10>
    <cef:ExpenseExampleYear01
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-467"
      unitRef="Unit_USD">150</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-468"
      unitRef="Unit_USD">378</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-469"
      unitRef="Unit_USD">568</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="P02_29_2024To02_29_2024_YouWouldPayTheFollowingExpensesOnA1000InvestmentAssumingA50AnnualReturnResultingEntirelyFromNetRealizedCapitalGainsMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      id="ixv-470"
      unitRef="Unit_USD">918</cef:ExpenseExampleYears1to10>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_100772074"
          xlink:label="Fact_100772074"
          xlink:type="locator"/>
        <link:footnote id="FN_348140" xlink:label="FN_348140" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the Sales Agents&#x2019; commission of up to 1.50% with respect to the shares of common stock being sold in this offering. There is no guarantee that there will be any additional sales of our common stock pursuant to the Prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772074"
          xlink:to="FN_348140"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772075"
          xlink:label="Fact_100772075"
          xlink:type="locator"/>
        <link:footnote id="FN_348141" xlink:label="FN_348141" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The offering expenses of this offering are estimated to be approximately $0.7 million, of which we have incurred $0.4 million as of February 28, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772075"
          xlink:to="FN_348141"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772076"
          xlink:label="Fact_100772076"
          xlink:type="locator"/>
        <link:footnote id="FN_348142" xlink:label="FN_348142" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The expenses of administering our dividend reinvestment plan are included in other expenses.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772076"
          xlink:to="FN_348142"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772078"
          xlink:label="Fact_100772078"
          xlink:type="locator"/>
        <link:footnote id="FN_348143" xlink:label="FN_348143" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net assets attributable to common stock equals average net assets, which is calculated as the average of the net assets balances for the year ended December 31, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772078"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:footnote id="FN_348144" xlink:label="FN_348144" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Our base management fee is 1.75% of the average value of our total assets (other than cash and cash equivalents but including assets purchased with borrowed amounts). This item represents actual base management fees incurred for the year ended December 31, 2023. We may from time to time decide it is appropriate to change the terms of the investment advisory agreement with our investment advisor (the &#x201c;Investment Advisory Agreement&#x201d;). Under the 1940 Act, any material change to our Investment Advisory Agreement must be submitted to stockholders for approval. The 3.15% reflected in the table is calculated on our net assets (rather than our total assets). See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Investment Advisory Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form 10-K.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772078"
          xlink:to="FN_348144"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772079"
          xlink:label="Fact_100772079"
          xlink:type="locator"/>
        <link:footnote id="FN_348145" xlink:label="FN_348145" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This item represents actual fees incurred on pre-incentive fee net investment income (income incentive fee) and actual fees payable for the capital gains incentive fee for the year ended December 31, 2023. The capital gains incentive fee payable as of December 31, 2023 was $17.5 million. For the year ended December 31, 2023, we accrued capital gains incentive fees (reversal) of $2.4 million in accordance with generally accepted accounting principles in the United States (&#x201c;U.S. GAAP&#x201d;), which equals 0.46% of average net assets attributable to common stock; such amount has not been included in the estimated expenses figure reflected in the table above. The incentive fee consists of two parts: The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets, (including interest that is accrued but not yet received in cash), subject to a 2.0% quarterly (8.0% annualized) hurdle rate and a &#x201c;catch-up&#x201d; provision measured as of the end of each calendar quarter. Under this provision, in any calendar quarter, our investment advisor receives no incentive fee until our pre-incentive fee net investment income equals the hurdle rate of 2.0% but then receives, as a &#x201c;catch-up,&#x201d; 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than 2.5%. The effect of this provision is that, if pre-incentive fee net investment income exceeds 2.5% in any calendar quarter, our investment advisor will receive 20.0% of our pre-incentive fee net investment income as if a hurdle rate did not apply. The second part, payable annually in arrears, equals 20.0% of our realized capital gains net of realized capital losses and unrealized capital depreciation, if any, on a cumulative basis from inception through the end of the fiscal year (or upon the termination of the Investment Advisory Agreement, as of the termination date), less the aggregate amount of any previously paid capital gain incentive fees. In accordance with U.S. GAAP, we accrue the capital gains incentive fee in our consolidated financial statements considering the fair value of investments on that date (i.e., the amount of fee which would be payable under a hypothetical liquidation based on the fair value of investments as of that date), which differs from the calculation of the amount payable in cash by the inclusion of unrealized capital appreciation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772079"
          xlink:to="FN_348145"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772079"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772080"
          xlink:label="Fact_100772080"
          xlink:type="locator"/>
        <link:footnote id="FN_348146" xlink:label="FN_348146" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2023, we had outstanding SBA debentures of $210.0 million; we had $250.0 million outstanding of our (i) 4.75% notes due 2026 (the &#x201c;January 2026 Notes&#x201d;), and (ii) 3.50% notes due 2026 (the &#x201c;November 2026 Notes&#x201d; and together with the January 2026 Notes, the &#x201c;Notes&#x201d;); we had secured borrowings outstanding of $15.9 million; we had no outstanding borrowings under our senior secured revolving credit agreement with certain lenders party thereto and ING Capital, LLC, as administrative agent (the &#x201c;Credit Facility&#x201d;), which has a total commitment of $100.0 million. Interest payments on borrowed funds is based on estimated annual interest and fee expenses on outstanding SBA debentures, Notes, secured borrowings and borrowings under the Credit Facility as of December 31, 2023 with a weighted average stated interest rate of 4.346% as of that date. We also pay a commitment fee between 0.5% and 2.675% per annum based the unutilized commitment under our Credit Facility. We have estimated the annual interest expense on borrowed funds and caution you that our actual interest expense will depend on prevailing interest rates and our rate of borrowing, which may be substantially higher than the estimate provided in this table. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772080"
          xlink:to="FN_348146"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772080"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772081"
          xlink:label="Fact_100772081"
          xlink:type="locator"/>
        <link:footnote id="FN_348147" xlink:label="FN_348147" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other expenses represent our estimated annual operating expenses, as a percentage of net assets attributable to common shares estimated for the year ended December 31, 2023, including professional fees, directors&#x2019; fees, insurance costs, expenses of our dividend reinvestment plan and payments under the administration agreement based on our allocable portion of overhead and other expenses incurred by our administrator. See &#x201c;Business&#x2014;Management and Other Agreements&#x2014;Administration Agreement&#x201d; in Part I, Item 1 in our most recent Annual Report on Form 10-K. Other expenses exclude interest payments on borrowed funds, income tax (provision) benefit from realized gains on investments, income tax (provision) from deemed distribution of long term capital gains, and for issuances of debt securities or preferred stock, interest payments on debt securities and distributions with respect to preferred stock. &#x201c;Other expenses&#x201d; are based on actual other expenses for the year ended December 31, 2023. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772081"
          xlink:to="FN_348147"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772081"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772082"
          xlink:label="Fact_100772082"
          xlink:type="locator"/>
        <link:footnote id="FN_348148" xlink:label="FN_348148" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Total annual expenses, before base management fee waiver&#x201d; as a percentage of consolidated net assets attributable to common stock are higher than the total annual expenses percentage would be for a company that is not leveraged. We borrow money to leverage our net assets and increase our total assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772082"
          xlink:to="FN_348148"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772082"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772083"
          xlink:label="Fact_100772083"
          xlink:type="locator"/>
        <link:footnote id="FN_348149" xlink:label="FN_348149" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Board of Directors accepted a voluntary, non-contractual, and unconditional waiver from our investment adviser to exclude any investments recorded as secured borrowings as defined under U.S. GAAP from the base management fee payable as of December 31, 2023. The base management fee waived for the year ended December 31, 2023 was $0.3 million. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772083"
          xlink:to="FN_348149"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772083"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_100772084"
          xlink:label="Fact_100772084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772084"
          xlink:to="FN_348143"
          xlink:type="arc"/>
        <link:footnote id="FN_348150" xlink:label="FN_348150" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The SEC requires that the &#x201c;total annual expenses, net of base management fee waiver&#x201d; percentage be calculated as a percentage of net assets (defined as total assets less total liabilities), rather than the total assets, including assets that have been purchased with borrowed amounts. If the &#x201c;total annual expenses, net of base management fee waiver&#x201d; percentage were calculated instead as a percentage of average consolidated total assets, our &#x201c;total annual expenses, net of base management fee waiver&#x201d; would be 6.56% of average consolidated total assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_100772084"
          xlink:to="FN_348150"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
